These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Complete resolution of the symptoms of refractory Osgood-Schlatter disease following percutaneous fixation of the tibial tuberosity. Narayan N; Mitchell PD; Latimer MD BMJ Case Rep; 2015 Feb; 2015():. PubMed ID: 25678612 [TBL] [Abstract][Full Text] [Related]
15. Osgood-Schlatter disease: a 2020 update of a common knee condition in children. Ladenhauf HN; Seitlinger G; Green DW Curr Opin Pediatr; 2020 Feb; 32(1):107-112. PubMed ID: 31714260 [TBL] [Abstract][Full Text] [Related]
16. Benign bone tumours of tibial tuberosity clinically mimicking Osgood-Schlatter disease: a case series. Jamshidi K; Mirkazemi M; Izanloo A; Mirzaei A Int Orthop; 2019 Nov; 43(11):2563-2568. PubMed ID: 31511951 [TBL] [Abstract][Full Text] [Related]
17. Risk assessment of the onset of Osgood-Schlatter disease using kinetic analysis of various motions in sports. Itoh G; Ishii H; Kato H; Nagano Y; Hayashi H; Funasaki H PLoS One; 2018; 13(1):e0190503. PubMed ID: 29309422 [TBL] [Abstract][Full Text] [Related]
18. Osgood-Schlatter Disease in youth elite football: Minimal time-loss and no association with clinical and ultrasonographic factors. Schultz M; Tol JL; Veltman L; Kaaden van der L; Reurink G Phys Ther Sport; 2022 May; 55():98-105. PubMed ID: 35305497 [TBL] [Abstract][Full Text] [Related]
19. Assessing Knee Stability in Adolescent Athletes with Osgood-Schlatter Disease Using the Y-Balance Test. Hladky V; Kaplan A; Smetanova J; Havlas V Acta Chir Orthop Traumatol Cech; 2023; 90(2):108-115. PubMed ID: 37155999 [TBL] [Abstract][Full Text] [Related]
20. [How I treat ... Osgood-Schlatter disease]. Schrouff I; Magotteaux J; Gillet P Rev Med Liege; 2015 Apr; 70(4):159-62. PubMed ID: 26054164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]